Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;13(10):1161-9.
doi: 10.1038/nn.2647. Epub 2010 Sep 27.

Animal models of neuropsychiatric disorders

Affiliations
Review

Animal models of neuropsychiatric disorders

Eric J Nestler et al. Nat Neurosci. 2010 Oct.

Abstract

Modeling of human neuropsychiatric disorders in animals is extremely challenging given the subjective nature of many symptoms, the lack of biomarkers and objective diagnostic tests, and the early state of the relevant neurobiology and genetics. Nonetheless, progress in understanding pathophysiology and in treatment development would benefit greatly from improved animal models. Here we review the current state of animal models of mental illness, with a focus on schizophrenia, depression and bipolar disorder. We argue for areas of focus that might increase the likelihood of creating more useful models, at least for some disorders, and for explicit guidelines when animal models are reported.

PubMed Disclaimer

References

    1. Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602. - PubMed
    1. Kessler RC, et al. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20:359–364. - PMC - PubMed
    1. World Health Organization. World Health Report 2001. Geneva: World Health Organization; 2001.
    1. Nestler EJ, Hyman SE, Malenka RC. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. 2. McGraw-Hill; New York: 2009.
    1. Markou A, Chimmulera C, Geyer MA, Tricklebank M, Steckler T. Removing obstacles in neuroscience drug discovery: The future path for animal models. Neuropsychopharm. 2009;34:74–89. - PMC - PubMed

MeSH terms